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CHAPTER 24
The HPA-axis and immune function in burnout
Paula M.C. Mommersteeg1,, Cobi J. Heijnen2, Annemieke Kavelaars2 and Lorenz
J.P. van Doornen3
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Box 90153, 5000 LE, Tilburg, The Netherlands
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Homebox KC 03.068.0, P.O. Box 85090, 3508 AB Utrecht, The Netherlands
3Department of Clinical and Health Psychology, Utrecht University, P.O. Box 80.140, 3508 TC, Utrecht, The Netherlands
Abstract: Burnout results from chronic work stress. Its complaints may be related to HPA-axis distur-
bances or changes in immune function. In our studies the salivary cortisol awakening response, day-curve,
and the suppressed level after dexamethasone intake were not different in a burned-out group compared to
a control group. Nor was there a change in cortisol after a treatment period. Higher levels of DHEAS and
the monocyte released anti-inflammatory cytokine IL-10 were observed, however T-cell stimulated and
dexamethasone inhibited cytokine release were not affected. The increased IL-10 level may be related to an
increased sensitivity for infections.
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Introduction
Burnout is the ultimate outcome of a chronic
process in which work stress is supposed to play a
decisive role. People with burnout feel extremely
fatigued, have become alienated from their work,
experience reduced professional competence, and
report a whole range of complaints such as de-
pressed mood, increased irritability, inability to
relax, disrupted sleep, somatic complaints such as
aching muscles, headaches, gastro-intestinal prob-
lems, and concentration and memory problems
(Maslach et al., 2001). When we assume that
burnout is a stress-related syndrome, one may ex-
pect to find a disturbance in hypothalamus pitu-
itary adrenal (HPA)-axis functioning. Inadequate
glucocorticoid signaling has been suggested for
other stress-related syndromes like post-traumatic
stress disorder (PTSD), chronic fatigue syndrome
(CFS), and major depression disorder (MDD).
Reviewing the literature on burnout and related
stress-syndromes has led to the hypothesis that the
fatigue symptoms in burnout are related to a state
of hypocortisolism, and increased feedback sensi-
tivity of the HPA-axis (Heim et al., 2000). On the
other hand, the depressive symptoms would sug-
gest a hypercortisolemic state, and a relative non-
suppression in response to dexamethasone (DEX)
(Raison and Miller, 2003). Assuming a distur-
bance of the HPA-axis in burnout, we expected a
reduction in burnout complaints to be related to a
recovery of this disturbance. A longitudinal study
was set up to correlate changes in complaints with
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Glucocorticoids play a decisive role in immune
functioning. Cortisol inhibits pro-inflammatory
cytokine release, e.g., TNF-a, IFN-g, interleukin
(IL)-6 and IL-1, and stimulates anti-inflammatory
IL-10 and IL-4 release (Elenkov and Chrousos,
2002). Chronic psychosocial stress has been related
to impaired immune functioning leading to phys-
ical illness. This process may be mediated by
glucocorticoids through affecting the balance be-
tween pro- and anti-inflammatory cytokines (Kie-
colt-Glaser et al., 2002).
Results
The major finding of our study was the absence of
a disturbance in salivary cortisol parameters in
burnout. A burnout group (n ¼ 74) was compared
to a healthy control group (n ¼ 38). The burnout
persons were on sick leave, and had received a
clinical diagnosis for work-related neurasthenia
according to International Statistical Classification
of Diseases and Related Health Problems (ICD-
10) criteria. Primary Diagnostic and Statistical
Manual of Mental Disorders Edition IV (DSM-
IV) disorders such as MDD or anxiety disorder
were excluded. The cortisol awakening response
(CAR) was measured on 2 days at 0, 15, and
30min after awakening, and at noon, 18:00 h and
22:30 h to assess the diurnal cortisol course. A low-
dose (0.5mg) DEX was taken to test the feedback
sensitivity of the HPA-axis. The suppressed corti-
sol level after DEX intake was measured at 0, 15,
and 30min after awakening. The cortisol CAR,
day-curve and suppressed DEX level were not
different between the burnout and control group
(Mommersteeg et al., 2006a–c) AU :1(Fig. 1). Cortisol
was not related to fatigue or depression complaints
within the burnout group, thus showing no indi-
cation of an opposing hypo- or hyperfunction of
the HPA-axis, potentially masking the effect in
burnout.
Because there is considerable variation in corti-
sol levels between and within persons, it is quite
well possible that within a group burnout persons
the reduction of the burnout complaints will cova-
ry with the cortisol parameters after a treatment
and a follow-up period. This possibility was stud-
ied in the longitudinal part of the previous study
(Mommersteeg et al., 2006). Burnout complaints
were significantly reduced after a treatment period,
without a further reduction at follow-up. Com-
plaints remained substantially higher than norm














































































Fig. 1. Cortisol awakening response (CAR, left) and the suppressed CAR after dexamethasone intake (right) in the burnout group
before treatment, after treatment and at follow-up, and in the control group. There are no differences between the groups or within the
burnout group at consecutive measurements. Means and SEM are shown.
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awakening and after DEX intake (Fig. 1) showed,
however, no parallel changes with complaint re-
duction. Some isolated associations emerged; the
CAR (averaged over the three measurements) was
significantly correlated with initial exhaustion
level. A decrease in depressive symptoms corre-
lated with an increased CAR, whereas the decrease
in fatigue in time correlated with a decrease of the
CAR over the three measurements (Mommersteeg
et al., 2006). The latter findings are in contradic-
tion to the supposed hyper- and hypoactive state
of the HPA-axis in MDD and CFS, respectively,
and moreover explained only a minor part of the
variance in complaints within (3%) and between
(4%) the burnout individuals.
Immune and endocrine variables were studied in
another burnout group (n ¼ 56) and compared to
38 controls (Mommersteeg et al., 2006). Again no
deviations in the cortisol CAR, or in the DEX
suppression test (DST) were observed. The
dehydroepiandrosterone-sulphate (DHEAS) level
(but not the cortisol/DHEAS-ratio) was signifi-
cantly elevated in the burnout group. The burnout
group had significantly higher levels of the anti-
inflammatory cytokine IL-10 produced by LPS
stimulated monocytes (Fig. 2). The IL-10 produc-
tion of stimulated T-cells, however, was not differ-
ent from the control group, and neither were there
differences in the pro-inflammatory cytokine re-
lease of monocyte TNF-a (Fig. 2) or T-cell IFN-g.
The capacity of DEX to modulate pro- and anti-
inflammatory cytokine release in vitro did not
differ between the burnout and the control group,
nor was there a change in number of whole blood
counts of T-cells, B-cells, and NK-cells.
Discussion
The results show that there is no discernable dis-


















































































Fig. 2. Anti-inflammatory IL-10 (left) and pro-inflammatory TNF-a release (right) of LPS stimulated monocytes in the burnout and
control group. The burnout group had significantly higher levels of stimulated IL-10 (F(1,83) ¼ 9.01, p ¼ 0.004). Means and SEM are
shown.
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however, an increased production of IL-10 and
salivary DHEAS. These findings in a rather large
sample of clinical burnout persons raise doubts
about the existence of a relevant neuroendocrine
dysregulation in burnout as suggested by some
earlier studies. Still a variety of (neuroendocrine)
factors may show modest disturbances, altogether
leading to a state of ‘allostatic load’ in burnout
patients. Though studies in burnout and CFS that
included allostatic load parameters do not point in
that direction (Cleare, 2003; Grossi et al., 2003;
Schnorpfeil et al., 2003), this type of approach may
be a viable option for further research.
Another option is that central mechanisms are
dysregulated in burnout. To test this possibility the
combined DEX/corticotrophin releasing hormone
(CRH) test, or CRH or adrenocorticotropic hor-
mone (ACTH) infusion are useful techniques. One
may doubt however whether these invasive tech-
niques are acceptable as a research tool for this
(relatively) mild syndrome. Our results point to-
ward an increased stimulated monocyte IL-10 re-
lease and increased DHEAS levels in burnout.
DHEAS has immunostimulatory effects, and at
the same time its non-sulphatized form DHEA has
been found to reduce susceptibility to viral, bac-
terial, and protozoan infections (Chen and Parker,
2004). Thus the relevance of the increased DHEAS
level in burnout for immune function remains to
be determined. Macrophage IL-10 release inhibits
T-cell proliferation and suppresses the release of
pro-inflammatory cytokines like the anti-viral
IFN-g. People with burnout report more common
cold and flu-like infections (Mohren et al., 2003).
Moreover, vital exhaustion is related to an in-
creased pathogen burden, with higher IL-10 serum
levels (van der Ven et al., 2003). Therefore an in-
creased IL-10 response in burnout may be related
to an increased sensitivity for viral infections. Fu-
ture studies should reveal the relevance of these
findings.
When we started this research project we hy-
pothesized that the HPA-axis should show distur-
bances in burnout. The results showed the absence
of any obvious peripheral deviation in salivary
cortisol, nor feedback by DEX in burnout. The
correlational effects observed in the longitudinal
study are too modest to represent any clinical or
diagnostic value. Overall we conclude that in this
study no obvious disturbance of the HPA-axis in
burnout was demonstrated. The possibility of
some disturbance in immune function and the
hormone DHEAS in burnout deserves further at-




CAR cortisol awakening response
CFS chronic fatigue syndrome




DSM-IV Diagnostic and Statistical Man-
ual of Mental Disorders Edition
IV
DST dexamethasone suppression test
HPA-axis hypothalamus pituitary adrenal
axis
ICD-10 International Statistical Classifi-
cation of Diseases and Related
Health Problems
IL interleukin
MDD major depression disorder
PTSD post-traumatic stress disorder
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